P666: 1 YEAR RESULTS OF DASATINIB 70MG/DAY VERSUS 100MG/DAY IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE(CML-CP):A PROSPECTIVE RANDOMIZED CONTROLLED STUDY.

• Dan Yu,
• Hui Cheng,
• Jingming Guo,
• Rui Jiang,
• Youshan Zhang,
• Chucheng Wan,
• Jun Qin,
• Guolin Yuan,
• Shiming Chen,
• Zhuangzhi Yang,
• Junbin Hu,
• Yicheng Zhang,
• Weiming LI

Affiliations

Dan Yu

1 Wuhan No.1 Hospital Department of Hematology, Department of Hematology, Wuhan, China

Hui Cheng

2 Wuhan No.1 Hospital, Department of Hematology, Wuhan, China

Jingming Guo

3 Yichang Central People’s hospital, Department of Hematology, yichang, China

Rui Jiang

4 Jingmen No.1 people’s hospital, Department of Hematology, Jinmen, China

Youshan Zhang

5 Jingzhou No.1 People’s hospital, Department of Hematology, Jingzhou, China

Chucheng Wan

6 SHiyan taihe hospital, Department of Hematology, Shiyan, China

Jun Qin

7 Shiyan people’s hospital, Department of Hematology, shiyan

Guolin Yuan

8 Xiangyang central hospital, Department of Hematology, xiangyang, China

Shiming Chen

9 Huangshi central hospital, Department of Hematology, Huangshi, China

Zhuangzhi Yang

10 Suizhou Central Hospital corresponding, Department of Hematology, suizhou, China

Junbin Hu

11 Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Department of Hematology, Wuhan, China

Yicheng Zhang

12 Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology, Department of Hematology, Wuhan, China

Weiming LI

11 Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Department of Hematology, Wuhan, China